US banks' fintech investments. Healthcare vs tech. Top biotech startups.

B2B fake news = market sizings

Hi there,

Saw a few recent headlines about startups I wanted to share below.

Here's one:

And here's another:

And here's the third:

The three headlines above all show different examples of startup culture.

Of course, only headlines 1 and 3 are real. Nobody writes articles like #2. Articles 1 and 3 are digital catnip.

The tech ecosystem def has myriad problems and sometimes tends to drink its own "changing the world" kool-aid and this sort of stupidity should be called out, but pointing to some wild outliers like #1 and #3 above and using them as a way to say "look at how startup culture is" is frankly BS. Confirmation bias and all that good stuff.
If someone wants to write an article like #2 above, I'm happy to put you in touch with boring companies building good isht with happy teams.

Bank rank

We looked at fintech investments of the top ten US banks by assets from 2012 to 2017 year-to-date. The cohort’s three most active investors are Citi, Goldman Sachs, and JP Morgan Chase.

Fake B2B News

We've highlighted the BS of market sizings (Pick a number, any number) before by the likes of Gartner, consultants, etc.

I recently stumbled upon this post by Mark Suster where he relays a story that highlights the "science" of these estimates. It is gold. (see The Blurb for the entire post)

Note: We've also poked at the pseudo-science behind Gartner's magic quadrants and the hype cycle.

And for your viewing pleasure, here are some market sizing estimates of the AI market that range from $5.05B to $3T.

Yes trillion with a T.

Healthcare vs tech

We compared exits in the healthcare space and the tech space based on disclosed valuations for VC-backed US companies. Looking at median exit valuation over time, healthcare tends to trend significantly higher than tech.

Ya' mama

Actually some wisdom about grandma from Nassim Taleb.

I'm excited to hear Taleb spit some fire at The Future of Fintech

Use the code grandma to get $2000 off here today.

Latin America fintech market map

We're still working on a Latin America fintech market map.

If you're a LatAm fintech company or investor in LatAm fintech companies, ensure your profile is updated/added to CB Insights via The CBI Editor.

This will get it in front of our research team and potentially the 284,000+ on this newsletter.

Submit here by June 16th.

Cancer cures and pig transplants

We put together a list of 10 early-stage biotechnology startups to watch. Vir Biotechnology, developing treatments and methods of prevention for viral and bacterial conditions based on the concept of immune programming, is featured below.

Industry Standard

CB Insights data is the most trusted by those in the industry and the media. A few recent hits.

BuzzFeed News. Venessa Wong (@venessawwong) reports on Hampton Creek's rebranding and references CB Insights funding data.

The Hindu. A look at VC funding in Asia with a reference to CB Insights Asia Tech Investment Report.

Business Insider. Biz Carson (@bizcarson) writes about on-demand storage company Clutter's latest round of financing and quotes CB Insights' Marcelo Ballve (@ballve) on the subject.

I love you.


P.S. We'll be digging into the future of e-commerce in an upcoming briefing on June 21st. Don't miss out.

Visualizing where major US banks have invested in fintech

Since 2012, the top ten US banks by assets under management have participated in 72 rounds totaling $3.6B to 56 fintech companies. Check it out.
Tweet this 

Tech vs healthcare exit valuations

While healthcare sees larger valuations overall, tech's largest exits have been significantly higher than healthcare's. See the data.
Tweet this

10 early-stage biotech startups to watch

Startups are applying innovative techniques to cure the common cold, re-engineer the human microbiome, and fight against cancer. See the list.
Tweet this

The Blurb

A curated mix of articles worth sharing.

73.6%. The percentage of statistics that are made up, according to Mark Suster (@msuster).
Both Sides of the Table

Don't play with dead snakes. Richard Daly (@richarddaly) on killing projects before they kill you.
First Round Review

Going to market when no markets exist. Martin Casado (@martin_casado) shares lessons learned for going to market when you’re trying to create, and not just enter, an existing market category.

Culture add. Brad Feld (@bfeld) says when hiring, go for culture add, not culture fit.
Feld Thoughts

Early-stage company discussion. A conversation on how to raise money and how to succeed long-term.
Y Combinator

If you loved this newsletter, send it to a friend.
If you hated it, send it to an enemy.
All the data in this newsletter comes from CB Insights. Join NEA, Cisco & hundreds of other clients and get access to the industry's best private company data.

Sign up for access.
Copyright © 2017 CB Information Services, All rights reserved.
498 7th ave, 17th floor, New York, NY 10018